OnKure Therapeutics

0 followers


OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.

Employees

11-50

Links


Org chart

Anthony D. Piscopio
CEO & President
Collapse
Jim Winkler
Scientific Advisor
Jennifer Diamond
Chief Medical Officer
Duncan Walker
Chief Development Officer
Mark L. Boys
VP, Discovery Chemistry
Duncan W.
Chief Development Officer (cdo)
Samuel Agresta
Chief Medical Officer

Board & advisors

Susan Bates
Scientific Advisor
Lia Gore
Scientific Advisor
Xuedong Liu
Scientific Advisor
Keith Flaherty
Scientific Advisor
Kevin Koch
Scientific Advisor
Pamela Munster
Scientific Advisor